CliffBio
small molecule

UTIBRON NEOHALER

GLYCOPYRROLATE; INDACATEROL MALEATE

Loss of exclusivityOctober 2028latest FDA-listed patent expiry
CompanyNovartis →View the full company profile on CliffBio

Drug detail

Brand nameUTIBRON NEOHALER
Active ingredientGLYCOPYRROLATE; INDACATEROL MALEATE
Strength15.6MCG/INH;27.5MCG/INH
Dosage formPOWDER
RouteINHALATION
ModalitySmall molecule
FDA approvalOctober 2015
Marketing statusDISCN

Listed patents

PatentExpiresType
8182838October 2028product
8479730October 2028product

More from Novartis

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

UTIBRON NEOHALER patent cliff — loss of exclusivity October 2028 | CliffBio